In melanomas, ex vivo expansion of T-cells for adoptive cell transfer therapy was directly related to the amount of Gal3 secreted by tumor cells and blocking the lectin enhanced T-cell activation [117]. This evidence concerns the gene LGALS3 and melanoma.